Distinct clinical outcomes in pediatric tuberculosis: A study utilizing infant macaques exposed to aerosol

Katherine Turnbull1, Eunice Vincent1, Huanbin Xu1,2

  • 1Tulane National Primate Research Center (TNPRC), Covington, LA 70433, USA.

Iscience
|July 18, 2025
PubMed

Insights

Pediatric rhesus macaques exposed to low-dose Mycobacterium tuberculosis (Mtb) mimic natural childhood TB infection. This animal model aids in studying pediatric tuberculosis immunopathogenesis and treatment strategies.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Pediatric Medicine

Background:

  • Pediatric tuberculosis (TB) research requires relevant animal models to study Mycobacterium tuberculosis (Mtb) infections in children.
  • Current models often do not accurately reflect the natural course of pediatric TB.

Purpose of the Study:

  • To establish and validate a pediatric rhesus macaque model for Mycobacterium tuberculosis (Mtb) infection.
  • To investigate the immunopathogenesis of pediatric TB using this translational model.

Main Methods:

  • Infant rhesus macaques were exposed to controlled doses of aerosolized Mtb CDC1551.
  • Systematic monitoring included physical examinations, blood chemistry, radiography, and histopathology.

Main Results:

  • Low-dose Mtb exposure resulted in immune control similar to human infants.
  • High-dose Mtb exposure led to rapid dissemination, disease progression, and mortality.
  • The model recapitulated key aspects of pediatric TB infection.

Conclusions:

  • Aerosolized low-dose Mtb in infant macaques serves as a translational model for pediatric TB.
  • This model facilitates the study of pediatric tuberculosis immunopathogenesis and treatment in a clinical setting.

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
371
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
207
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
329
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
241
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
448